BE616646A
(pt)
|
|
|
|
|
DE1124485B
(de)
|
1960-02-12 |
1962-03-01 |
Hoechst Ag |
Verfahren zur Herstellung von analeptisch wirksamen Phenylcycloalkylmethylaminen
|
US3496181A
(en)
*
|
1966-10-24 |
1970-02-17 |
Upjohn Co |
2 - aminocycloalkyl hydroquinones,esters,ethers and n-oxides thereof,and a process for preparing the same
|
GB1207731A
(en)
*
|
1968-05-14 |
1970-10-07 |
Reckitt & Sons Ltd |
Derivatives of pyrrolidine
|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
US3974157A
(en)
|
1974-03-04 |
1976-08-10 |
Pennwalt Corporation |
1-(Amino-alkyl)-2-aryl-cyclohexane alcohols and esters
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
US4287212A
(en)
*
|
1976-04-30 |
1981-09-01 |
American Hoechst Corporation |
2-Aryl-1,2-dialkylcycloalkylamines
|
JPS6033106B2
(ja)
|
1977-10-07 |
1985-08-01 |
住友化学工業株式会社 |
カルボン酸エステル、その製造法およびそれを有効成分とする殺虫、殺ダニ剤
|
ZA817261B
(en)
|
1980-10-23 |
1982-09-29 |
Schering Corp |
Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
|
US4540690A
(en)
|
1982-02-09 |
1985-09-10 |
The Upjohn Company |
2-(Phenylmethylene)cycloalkylamines and -azetidines
|
ZA829562B
(en)
*
|
1982-02-09 |
1983-10-26 |
Upjohn Co |
2-(phenylmethylene)cycloalkylamines and-azetidines
|
JPS58177915A
(ja)
|
1982-04-12 |
1983-10-18 |
Green Cross Corp:The |
抗血栓剤
|
EP0152032B1
(en)
|
1984-02-03 |
1988-10-26 |
Olympus Optical Co., Ltd. |
Calculus crushing apparatus
|
JPS60172970A
(ja)
*
|
1984-02-15 |
1985-09-06 |
Shionogi & Co Ltd |
シス−アゾリルシクロアルカノ−ル誘導体およびその製造法ならびに農業用殺菌剤
|
EP0190224A1
(en)
|
1984-07-30 |
1986-08-13 |
Schering Corporation |
PROCESS FOR THE PREPARATION OF CIS, ENDOOCTAHYDROCYCLOPENTA [b] PYRROLE-2-CARBOXYLATE
|
DE3431541A1
(de)
|
1984-08-28 |
1986-03-06 |
Hoechst Ag, 6230 Frankfurt |
Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
US4738709A
(en)
|
1985-01-10 |
1988-04-19 |
Ppg Industries, Inc. |
Herbicidally active substituted benzisoxazoles
|
US4751231A
(en)
|
1987-09-16 |
1988-06-14 |
Merck & Co., Inc. |
Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
|
JPH01172388A
(ja)
|
1987-12-25 |
1989-07-07 |
Sumitomo Chem Co Ltd |
チエノ〔3,2−b〕ピロロ〔2,3−d〕ピロール類およびその製法
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
US4981870A
(en)
|
1989-03-07 |
1991-01-01 |
Pfizer Inc. |
Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
PT93943A
(pt)
|
1989-05-05 |
1991-02-08 |
Searle & Co |
Processo para a preparacao de composicoes contendo compostos indole-2-carboxilato para tratamento de perturbacoes do snc
|
ATE172712T1
(de)
|
1989-05-31 |
1998-11-15 |
Upjohn Co |
Zns-wirksame 8-heterocyclyl-2-aminotetralin derivate
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
AU646432B2
(en)
*
|
1990-02-02 |
1994-02-24 |
Schering Corporation |
4,5-cycloalkano-3-benzazepin-7-ol-derivatives and their use
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
JPH0477476A
(ja)
|
1990-07-19 |
1992-03-11 |
Sankyo Co Ltd |
抗潰瘍剤
|
US5086054A
(en)
|
1990-07-31 |
1992-02-04 |
Sri International |
Novel arylcycloalkanepolyalkylamines
|
JP3007138B2
(ja)
|
1990-11-27 |
2000-02-07 |
ファイザー製薬株式会社 |
新規なヒドロキサム酸とn―ヒドロキシ尿素誘導体およびそれらの組成物
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
GB9208492D0
(en)
|
1992-04-16 |
1992-06-03 |
Glaxo Spa |
Heterocyclic compounds
|
JP3457669B2
(ja)
|
1992-10-28 |
2003-10-20 |
富山化学工業株式会社 |
新規な1,2−ベンゾイソオキサゾール誘導体またはその塩,それらからなる脳保護剤
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
GB9304500D0
(en)
|
1993-03-05 |
1993-04-21 |
Glaxo Spa |
Heterocyclic compounds
|
ES2081747B1
(es)
|
1993-09-07 |
1997-01-16 |
Esteve Labor Dr |
Amidas derivadas de tienopirroles, su preparacion y su aplicacion como medicamentos.
|
GB9321221D0
(en)
|
1993-10-14 |
1993-12-01 |
Glaxo Spa |
Heterocyclic compounds
|
GB9326284D0
(en)
|
1993-12-23 |
1994-02-23 |
Erba Carlo Spa |
Pyrrolydenemethyl-derivatives and process for their preparation
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
CN1047384C
(zh)
|
1994-07-28 |
1999-12-15 |
北京大学 |
雷米普利的合成方法
|
WO1996006837A1
(fr)
|
1994-08-30 |
1996-03-07 |
Sankyo Company, Limited |
Isoxazoles
|
US5484763A
(en)
|
1995-02-10 |
1996-01-16 |
American Cyanamid Company |
Substituted benzisoxazole and benzisothiazole herbicidal agents
|
US5620997A
(en)
|
1995-05-31 |
1997-04-15 |
Warner-Lambert Company |
Isothiazolones
|
US5859042A
(en)
|
1995-09-27 |
1999-01-12 |
Ono Pharmaceutical Co., Ltd. |
Five membered heterocyclic compounds
|
EP0940387B1
(en)
|
1995-10-26 |
2003-05-07 |
Mitsubishi Pharma Corporation |
Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same
|
UA48216C2
(uk)
*
|
1996-01-31 |
2002-08-15 |
Бік Гулден Ломберг Кеміше Фабрік Гмбх |
Фенантридини та лікарський засіб для лікування захворювань дихальних шляхів
|
DE19711785A1
(de)
|
1997-03-21 |
1998-09-24 |
Merck Patent Gmbh |
Endothelin-Rezeptor-Antagonisten
|
US6503582B1
(en)
|
1997-08-19 |
2003-01-07 |
Mattel, Inc. |
Fluid-swellable composition, device and method for using the same
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
WO1999018065A1
(en)
|
1997-10-03 |
1999-04-15 |
Chirotech Technology Limited |
Chiral amines
|
GB9803226D0
(en)
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
GB9803228D0
(en)
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
AU3363599A
(en)
|
1998-03-26 |
1999-10-18 |
Max-Planck Institut Fur Biochemie |
Heterocyclic families of compounds for the modulation of tyrosine protein kinase
|
US6476078B2
(en)
|
1999-08-11 |
2002-11-05 |
Sepracor, Inc. |
Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
|
US6632836B1
(en)
|
1998-10-30 |
2003-10-14 |
Merck & Co., Inc. |
Carbocyclic potassium channel inhibitors
|
KR20010080364A
(ko)
*
|
1998-12-02 |
2001-08-22 |
마르크 젠너 |
치료제 및 그 용도
|
US6828460B2
(en)
*
|
1999-03-22 |
2004-12-07 |
Pfizer Inc. |
Resorcinol derivatives
|
DE19915601A1
(de)
|
1999-04-07 |
2000-10-19 |
Gruenenthal Gmbh |
3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
|
FR2795733B1
(fr)
|
1999-06-30 |
2001-09-07 |
Aventis Pharma Sa |
Derives de streptogramines, leur preparation et les compositions qui les contiennent
|
EP1391460A1
(en)
|
1999-09-30 |
2004-02-25 |
Pfizer Products Inc. |
Tricyclic pyrrolyl amides as glycogen phosphorylase inhibitors
|
DE60007592T2
(de)
|
1999-09-30 |
2004-09-16 |
Pfizer Products Inc., Groton |
Bicyclische Pyrrolylamide als Glycogenphosphorylase-Inhibitoren
|
ES2231275T3
(es)
|
1999-10-08 |
2005-05-16 |
Affinium Pharmaceuticals, Inc. |
Inhibidores de fab i.
|
AU1572301A
(en)
*
|
1999-12-08 |
2001-06-18 |
Eli Lilly And Company |
Cyclopentyl sulfonamide derivatives
|
DE19960917A1
(de)
|
1999-12-17 |
2001-06-21 |
Bayer Ag |
Neue 3-Oxo-2,1-benzisoxazol-1(3H)-carboxamide zur Behandlung von ZNS-Erkrankungen
|
DE10000312A1
(de)
|
2000-01-05 |
2001-07-12 |
Gruenenthal Gmbh |
Substituierte Aminomethyl-Phenyl-Cyclohexanderivate
|
JP2001247462A
(ja)
|
2000-03-07 |
2001-09-11 |
Otsuka Pharmaceut Co Ltd |
ウレアーゼ阻害剤
|
US6632417B2
(en)
|
2000-03-07 |
2003-10-14 |
Chevron U.S.A. Inc. |
Process for preparing zeolites
|
EP1136071A3
(en)
|
2000-03-22 |
2003-03-26 |
Pfizer Products Inc. |
Use of glycogen phosphorylase inhibitors
|
EP1188756B1
(en)
|
2000-04-19 |
2004-06-23 |
Kaneka Corporation |
Novel azetidine derivative and process for preparation thereof
|
GB0012214D0
(en)
|
2000-05-19 |
2000-07-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
JP2004505982A
(ja)
|
2000-08-04 |
2004-02-26 |
イーライ・リリー・アンド・カンパニー |
新規なsPLA2インヒビター
|
GB0021831D0
(en)
|
2000-09-06 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
DE10049483A1
(de)
*
|
2000-09-29 |
2002-05-02 |
Gruenenthal Gmbh |
Substituierte 1-Aminobutan-3-ol-Derivate
|
DE10049481A1
(de)
*
|
2000-09-29 |
2002-05-02 |
Gruenenthal Gmbh |
Substituierte C-Cyclohexylmethylamin-Derivate
|
WO2002031128A1
(en)
|
2000-10-06 |
2002-04-18 |
Smithkline Beecham Corporation |
Methods of agonizing and antagonizing fabk
|
EP1334087A1
(en)
*
|
2000-10-13 |
2003-08-13 |
Eli Lilly And Company |
Cycloalkylfluorosulfonamide derivatives
|
SE0003810D0
(sv)
|
2000-10-20 |
2000-10-20 |
Pharmacia Ab |
Novel compounds their use and preparations
|
TWI283575B
(en)
|
2000-10-31 |
2007-07-11 |
Eisai Co Ltd |
Medicinal compositions for concomitant use as anticancer agent
|
DE10063992A1
(de)
|
2000-12-21 |
2002-07-04 |
Max Planck Gesellschaft |
Tryptophan-Analoga in Proteinen, Peptiden und peptidischen Leitstrukturen
|
US6372919B1
(en)
|
2001-01-11 |
2002-04-16 |
Dov Pharmaceutical, Inc. |
(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
|
US20020123490A1
(en)
|
2001-03-01 |
2002-09-05 |
Pfizer Inc. |
Combination treatment for anxiety, depression, obsessive compulsive disorder and psychosis
|
WO2003000657A1
(fr)
|
2001-06-20 |
2003-01-03 |
Daiichi Pharmaceutical Co., Ltd. |
Derives de diamine
|
GB0115602D0
(en)
|
2001-06-26 |
2001-08-15 |
Syngenta Participations Ag |
Organic compounds
|
DE10132747A1
(de)
*
|
2001-07-05 |
2003-01-23 |
Gruenenthal Gmbh |
Substituierte 1-Aryl-but-3-enylamin- und 1-Aryl-but-2-enylaminverbindungen
|
US6603000B2
(en)
|
2001-07-11 |
2003-08-05 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Synthesis for heteroarylamine compounds
|
CA2456841A1
(en)
|
2001-08-09 |
2003-02-27 |
Daiichi Pharmaceutical Co., Ltd. |
Cyclohexyl and piperidine diamine derivatives useful as activated blood coagulation factor x inhibitors
|
US7045543B2
(en)
|
2001-11-05 |
2006-05-16 |
Enzrel Inc. |
Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
|
US20030162825A1
(en)
|
2001-11-09 |
2003-08-28 |
Sepracor Inc. |
D-amino acid oxidase inhibitors for learning and memory
|
WO2003048113A1
(en)
*
|
2001-11-30 |
2003-06-12 |
Sepracor Inc. |
Tramadol analogs and uses thereof
|
DE10164581A1
(de)
*
|
2001-12-14 |
2003-06-26 |
Gruenenthal Gmbh |
Substituierte Aminoalkohole
|
DE10161809A1
(de)
*
|
2001-12-14 |
2003-06-26 |
Gruenenthal Gmbh |
Arzneimittel enthaltend N,N'-disubstituierte Piperazin-Verbindungen
|
TW200307539A
(en)
|
2002-02-01 |
2003-12-16 |
Bristol Myers Squibb Co |
Cycloalkyl inhibitors of potassium channel function
|
JP4538232B2
(ja)
*
|
2002-02-11 |
2010-09-08 |
ロディア・シミ |
ブロックコポリマーを含む洗浄組成物
|
GB0205165D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
GB0205170D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
JPWO2003091213A1
(ja)
|
2002-04-25 |
2005-09-02 |
アステラス製薬株式会社 |
新規なアミド誘導体又はその塩
|
EP1501800A1
(en)
|
2002-05-03 |
2005-02-02 |
Warner-Lambert Company LLC |
Bombesin antagonists
|
FR2841487B1
(fr)
|
2002-06-26 |
2004-08-20 |
Solystic |
Procede de detection de plis simples et de plis en prise multiple dans une installation de tri postal
|
DE10233048A1
(de)
*
|
2002-07-19 |
2004-01-29 |
Grünenthal GmbH |
Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken
|
US20050182131A1
(en)
*
|
2002-07-19 |
2005-08-18 |
Gruenenthal Gmbh |
1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
|
AU2003252299A1
(en)
|
2002-07-31 |
2004-02-16 |
Eisai Co., Ltd. |
Novel physiologically active substance
|
US7537891B2
(en)
|
2002-08-27 |
2009-05-26 |
Bristol-Myers Squibb Company |
Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
|
EP1543011B1
(en)
|
2002-09-06 |
2006-05-03 |
Janssen Pharmaceutica N.V. |
Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
|
NZ538741A
(en)
|
2002-09-16 |
2007-01-26 |
Sepracor Inc |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
|
EP1545485A2
(en)
|
2002-09-16 |
2005-06-29 |
Sepracor Inc. |
Treatment of cns disorders with trans-4- (3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine
|
TW200418838A
(en)
*
|
2002-09-18 |
2004-10-01 |
Bristol Myers Squibb Co |
Compounds for the treatment of premature ejaculation
|
US20040106681A1
(en)
|
2002-10-03 |
2004-06-03 |
Cypress Bioscience, Inc. |
Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
|
GB0222909D0
(en)
|
2002-10-03 |
2002-11-13 |
Astrazeneca Ab |
Novel process and intermediates
|
GB0222912D0
(en)
|
2002-10-03 |
2002-11-13 |
Astrazeneca Ab |
Novel process and intermediates
|
US20040097554A1
(en)
|
2002-10-30 |
2004-05-20 |
Pfizer Inc |
Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
|
BR0316099A
(pt)
|
2002-11-07 |
2005-09-27 |
Pfizer Prod Inc |
Agentes antidiabéticos
|
KR100998796B1
(ko)
|
2003-01-31 |
2010-12-06 |
가부시키가이샤산와카가쿠켄큐쇼 |
디펩티딜 펩티다아제 iv를 저해하는 화합물
|
ATE482747T1
(de)
|
2003-04-11 |
2010-10-15 |
High Point Pharmaceuticals Llc |
Neue amide derivate und deren pharmazeutische verwendungen
|
WO2004096768A1
(en)
|
2003-04-30 |
2004-11-11 |
Pfizer Products Inc. |
Anti-diabetic agents
|
WO2004113345A1
(ja)
|
2003-06-20 |
2004-12-29 |
Japan Tobacco Inc. |
縮合ピロール化合物及びその医薬用途
|
ATE360638T1
(de)
|
2003-06-30 |
2007-05-15 |
Servier Lab |
Verfahren für die synthese von perindopril und seiner pharmazeutisch geeigneten salze
|
KR20060033780A
(ko)
|
2003-07-07 |
2006-04-19 |
시바 스페셜티 케미칼스 홀딩 인크. |
푸로피롤의 제조방법
|
NZ601772A
(en)
|
2003-07-29 |
2012-10-26 |
Signature R & D Holdings Llc |
Amino Acid Prodrugs
|
GB0318463D0
(en)
|
2003-08-07 |
2003-09-10 |
Astrazeneca Ab |
Chemical compounds
|
GB0319759D0
(en)
|
2003-08-22 |
2003-09-24 |
Astrazeneca Ab |
Chemical compounds
|
WO2005020986A1
(en)
|
2003-08-29 |
2005-03-10 |
Astrazeneca Ab |
Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
|
GB0320422D0
(en)
|
2003-08-30 |
2003-10-01 |
Astrazeneca Ab |
Chemical compounds
|
BRPI0415833A
(pt)
|
2003-10-23 |
2007-01-02 |
Hoffmann La Roche |
derivados de triaza-espiropiperidina para uso como inibidores de glyt-1 no tratamento de distúrbios neurológicos e neuropsiquiátricos
|
US7396940B2
(en)
|
2003-10-23 |
2008-07-08 |
Hoffmann-La Roche Inc. |
Combinatorial library of 3-aryl-1H-indole-2-carboxylic acid
|
ATE354586T1
(de)
|
2003-11-19 |
2007-03-15 |
Servier Lab |
Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen
|
KR20060128976A
(ko)
|
2003-12-29 |
2006-12-14 |
세프라코 아이엔시. |
피롤 및 피라졸 디에이에이오 억제제
|
PL380766A1
(pl)
|
2003-12-29 |
2007-03-19 |
Sepracor Inc. |
Benzo[d]izooksazol-3- olowe inhibitory DAAO
|
US20070197610A1
(en)
|
2004-03-16 |
2007-08-23 |
Janssen Pharmaceutica N.V. |
Benzisoxazoles
|
CN1950351B
(zh)
|
2004-05-07 |
2012-01-18 |
沃尼尔·朗伯有限责任公司 |
适用作h3配体的3-或4-单取代酚及苯硫酚衍生物
|
JP5420170B2
(ja)
*
|
2004-05-14 |
2014-02-19 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
カルボキサミド系オピオイド化合物
|
CN1956975A
(zh)
*
|
2004-05-21 |
2007-05-02 |
默克公司 |
趋化因子受体活性的氨基环戊基杂环和碳环调节剂
|
JP4101852B2
(ja)
|
2004-05-26 |
2008-06-18 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
シンナミド化合物
|
WO2005123677A1
(en)
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
|
ES2437755T3
(es)
|
2004-07-01 |
2014-01-14 |
Daiichi Sankyo Company, Limited |
Intermedios para derivados de tienopirazol que tienen actividad inhibitoria de PDE 7
|
US7276631B2
(en)
*
|
2004-07-20 |
2007-10-02 |
Bristol-Myers Squibb Company |
Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists
|
JO2629B1
(en)
|
2004-08-19 |
2012-06-24 |
افينتيس فارما سوتيكالز انك |
Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon
|
US7411093B2
(en)
|
2004-12-20 |
2008-08-12 |
Hoffman-La Roche Inc. |
Aminocycloalkanes as DPP-IV inhibitors
|
US20090069384A1
(en)
|
2005-01-19 |
2009-03-12 |
Biolipox Ab |
Thienopyrroles useful in the treatment of inflammation
|
CN100391945C
(zh)
|
2005-05-31 |
2008-06-04 |
浙江大学 |
一种s-(-)-吲哚啉-2-羧酸的合成方法
|
US20090306169A1
(en)
|
2005-10-06 |
2009-12-10 |
Brandish Philip E |
Use of Fused Pyrrole Carboxylic Acids for the Treatment of Neurodegenerative and Psychiatric Diseases and D-Amino Acid Oxidase Inhibitors
|
UA95788C2
(en)
|
2005-12-15 |
2011-09-12 |
Ф. Хоффманн-Ля Рош Аг |
Fused pyrrole derivatives
|
EP1978961B1
(en)
|
2006-01-06 |
2016-03-16 |
Sunovion Pharmaceuticals Inc. |
Tetralone-based monoamine reuptake inhibitors
|
EP1976513B1
(en)
|
2006-01-06 |
2016-08-24 |
Sunovion Pharmaceuticals Inc. |
Cycloalkylamines as monoamine reuptake inhibitors
|
DK2816024T3
(en)
|
2006-03-31 |
2017-10-30 |
Sunovion Pharmaceuticals Inc |
CHIRALE AMINER
|
US7884124B2
(en)
|
2006-06-30 |
2011-02-08 |
Sepracor Inc. |
Fluoro-substituted inhibitors of D-amino acid oxidase
|
US7579370B2
(en)
|
2006-06-30 |
2009-08-25 |
Sepracor Inc. |
Fused heterocycles
|
US20080058395A1
(en)
|
2006-06-30 |
2008-03-06 |
Sepracor Inc. |
Fused heterocyclic inhibitors of D-amino acid oxidase
|
WO2008005456A2
(en)
|
2006-06-30 |
2008-01-10 |
Sepracor Inc. |
Fused heterocyclic inhibitors of d-amino acid oxidase
|
CN1962656A
(zh)
|
2006-11-29 |
2007-05-16 |
沈阳药科大学 |
吲哚美辛5-氟尿嘧啶甲酯药用化合物及其制剂和制备方法
|
MX2009006751A
(es)
|
2006-12-21 |
2009-06-30 |
Abbott Lab |
Compuestos agonistas y antagonistas del receptor de esfingosina-1-fosfato.
|
US7902252B2
(en)
|
2007-01-18 |
2011-03-08 |
Sepracor, Inc. |
Inhibitors of D-amino acid oxidase
|
AU2008206039A1
(en)
|
2007-01-18 |
2008-07-24 |
Sepracor Inc. |
Inhibitors of D-amino acid oxidase
|
MX2009012685A
(es)
*
|
2007-05-31 |
2009-12-14 |
Sepracor Inc |
Cicloalquilaminas sustituidas con fenilo como inhibidores de la reabsorcion de monoamina.
|
US20100120740A1
(en)
|
2008-08-07 |
2010-05-13 |
Sepracor Inc. |
Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
|